DadFinStart your free week
DadFin › Stocks › Real Estate › LTC

LTC Properties, Inc. (LTC) stock score

Real Estate · REIT - Healthcare Facilities · United States

$42.46 ▲ +0.98% today

92.3
Dad Score, out of 100
strong

LTC Properties, Inc. (LTC) is a REIT - Healthcare Facilities company in the Real Estate sector, listed in the United States. On DadFin's weekly run it scores 92.3 out of 100 on the Dad Score, a strong reading that places the business ahead of 92% of the 5,774 US and Canadian stocks DadFin fully scores. Inside Real Estate it ranks #12 of 240. Its strongest axes are quality, growth and price action; its weakest are valuation and conviction.

Scores from the run of Oct 4, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →

The eight axes

Valuation
Below average
Quality
Strong
Growth
Above average
Price action
Strong
Risk
Above average
Conviction
Below average
Liquidity
Weak
Macro
Strong

Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.

Key numbers

P/E (trailing)15.4×
P/E (forward)27.3×
Dividend yield5.34%
Return on capital8.8%
Operating margin32.7%
Revenue growth (YoY)+25.3%
FCF yield4.2%
Net debt / EBITDA5.61×
Piotroski F-Score6 / 9
52-week change+30.2%
Market cap$2.3B
Next earningsNov 3, 2026

What subscribers see on LTC

Start your free weekSubscriber? Open the full research →

REIT - Healthcare Facilities peers

StockCompanyDad ScoreBandMarket cap
WELLWelltower Inc.46.6middling$164.1B
VTRVentas, Inc.41.7middling$43.1B
OHIOmega Healthcare Investors, Inc.77.0good$14.4B
DOCHealthpeak Properties, Inc.37.7weak$13.8B
AHRAmerican Healthcare REIT, Inc.51.5middling$11.1B
CTRECareTrust REIT, Inc.29.1weak$8.6B
SBRASabra Health Care REIT, Inc.35.0weak$4.9B
NHINational Health Investors, Inc.82.4good$3.2B

Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 4, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.